NRx Pharmaceuticals Inc. (NRXP) |
|
10.03 -0.11 (-1.08%)
|
09-23 13:34 |
|
Open: |
10.14 |
Pre. Close: |
10.14 |
|
High:
|
10.17 |
Low:
|
9.82 |
|
Volume:
|
526,978 |
Market Cap:
|
539M |
|
|
|
|
Big Rock Partners Acquisition Corp. is a blank check company. The Company is formed for the purpose of entering into a merger, stock exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. The Company is not limited to a particular industry or geographic region for purposes of consummating a business combination. The Company has not commenced any business operation and has not generated any revenue. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
10.549 - 10.624 |
10.624 - 10.681 |
|
Low:
|
9.776 - 9.852 |
9.852 - 9.911 |
|
Close:
|
10.327 - 10.449 |
10.449 - 10.543 |
|
Technical analysis |
as of: 2021-09-23 1:23:24 PM |
|
Overall:
|
 |
| Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 17.56 One year: 21.37 |
| Support: |
Support1: 9.75 Support2: 8.11 |
| Resistance: |
Resistance1: 15.03 Resistance2: 18.30 |
| Pivot: |
12.29  |
| Moving Average: |
MA(5): 10.36 MA(20): 12.75
MA(100): 19.30 MA(250): |
| MACD: |
MACD(12,26): -1.12 Signal(9): -0.83 |
| Stochastic oscillator: |
%K(14,3): 6.22 %D(3): 6.42 |
| RSI: |
RSI(14): 39.45 |
| 52-week: |
High: 76.99 Low: 8.39 Change(%): -6.4 |
| Average Vol(K): |
3-Month: 9555955 10-Days: 152250 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.NRXP has closed above bottom band by 22.9%. Bollinger Bands are 57.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to NRXP's normal range. The bands have been in this narrow range for {EMPTY} bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Thu, 16 Sep 2021
NRX (NRXP) falls 9.33% to Close at $10.50 on September 16 - Equities.com
Tue, 14 Sep 2021
IQVIA (IQV) Announces Collaboration With NRx Pharmaceuticals - Nasdaq
Mon, 13 Sep 2021
IQVIA and NRx Pharmaceuticals Collaborate on Potential Medical Support for Novel COVID-19 Treatment - Business Wire
Fri, 10 Sep 2021
NRx Pharmaceuticals : Business description of NRX Pharmaceuticals, Inc., excerpted from the Form S-1 (Form 8-K) - Marketscreener.com
Wed, 08 Sep 2021
NRx Pharmaceuticals to Participate in HC Wainwright 23rd Annual Global Investment Conference - PRNewswire
Mon, 30 Aug 2021
NRx Pharmaceuticals Announces New Finding from ZYESAMI™ (aviptadil) Phase 2b/3 Clinical Trial Demonstrating Clinically Significant Relief from Respiratory Distress in Critical COVID-19 - PRNewswire
|
Financial Analysis |
| Growth |
NA |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
NA |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
NA |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
NA |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Underperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Underperform |
Price to Earnings: |
Underperform |
| Return on Equity: |
Outperform |
Debt to Equity: |
Underperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Financial Services |
| Industry: Biotechnology |
| Shares Out. (M) |
47 |
| Shares Float (M) |
8 |
|
% Held by Insiders
|
56.23 |
|
% Held by Institutions
|
1.14 |
|
Shares Short (K)
|
94 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
|
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
|
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
|
|
Return on Equity (ttm)
|
|
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
-0.331 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-4 |
|
Levered Free Cash Flow (M)
|
|
Stock Valuations |
|
PE Ratio
|
|
|
PEG Ratio
|
|
|
Price to Book value
|
|
|
Price to Sales
|
|
|
Price to Cash Flow
|
-108.14 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
